$2.37
0.26[12.32%]
At close: May 8
$2.37
0[0.00%]
After Hours: 7:47PM EDT
Cyclacel Pharmaceuticals
(NASDAQ:CYCC)Cyclacel Pharmaceuticals Stock (NASDAQ:CYCC), Quotes and News Summary
Cyclacel Pharmaceuticals Stock (NASDAQ: CYCC) stock price, news, charts, stock research, profile.
| Open | $2.130 |
| Close | $2.320 |
| Volume / Avg. | 326.504K / 784.744K |
| Day Range | 2.060 - 2.496 |
| 52 Wk Range | 1.300 - 13.200 |
| Market Cap | $3.124M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 55 |
| Short Interest | 3.11% |
| Days to Cover | 1.72 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cyclacel Pharmaceuticals (CYCC) stock?
You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ: CYCC) through any online brokerage.
Who are Cyclacel Pharmaceuticals's (CYCC) competitors?
Other companies in Cyclacel Pharmaceuticals’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Geovax Labs (NASDAQ:GOVX) and Finch Therapeutics Gr (NASDAQ:FNCH).
What is the target price for Cyclacel Pharmaceuticals (CYCC) stock?
The latest price target for Cyclacel Pharmaceuticals (NASDAQ: CYCC) was reported by Roth MKM on Friday, May 3, 2024. The analyst firm set a price target for 11.00 expecting CYCC to rise to within 12 months (a possible 364.14% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cyclacel Pharmaceuticals (CYCC)?
The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $2.37 last updated May 8, 2024 at 7:47 PM EDT.
Does Cyclacel Pharmaceuticals (CYCC) pay a dividend?
There are no upcoming dividends for Cyclacel Pharmaceuticals.
When is Cyclacel Pharmaceuticals (NASDAQ:CYCC) reporting earnings?
Cyclacel Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Cyclacel Pharmaceuticals (CYCC) going to split?
There is no upcoming split for Cyclacel Pharmaceuticals.
What sector and industry does Cyclacel Pharmaceuticals (CYCC) operate in?
Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.